3D Printing in Hospitals Forum

Dr. Michael Wagels

Plastic and Reconstructive Surgeon. Princess Alexandra Hospital

Dr. Michael Wagels completed FRACS in Plastic and Reconstructive Surgery in 2012 and fellowships in cranio-maxillofacial surgery and surgery of the hand and wrist. He has a special interest in complex lower limb reconstruction, hand and wrist surgery, reanimation of the upper limb, and head and neck reconstructive surgery, including craniofacial surgery. He is also interested in the translational aspects of tissue engineering for complex reconstructive defects, including long-segment nerve injuries. In 2019, he was appointed Director of the Australian Centre for Complex Integrated Surgical Solutions (ACCISS) at the Translational Research Institute. Michael was appointed Clinical Director of the Herston Biofabrication Institute (HBI) at the Royal Brisbane and Women’s Hospital in 2020.

Ishaque Khan

Director Clinical technology. Hunter New England Health District, NSW Health

Ishaque Khan holds a master's degree in biomedical engineering and medical imaging from University College London. He is certified in healthcare quality, occupational health, and safety, and is on the Australian engineering register. As the Director of Clinical Technology at HNE LHD, NSW Health, Ishaque Khan leads a portfolio of health technology, quality improvement, patient safety, innovation, and sustainability programs and initiatives across one of the largest local health districts in NSW. With over 23 years of experience, Ishaqie Khan has developed and implemented performance improvement frameworks, quality and safety plans, medical technology and device management strategies, medtech development, and 3D printing projects in partnership with academic and industrial stakeholders. 

Dr. Masako Dunn

Head and Neck Cancer Research and Innovation Manager. Chris O' Brien Lifehouse

Dr. Masako Dunn is the Research and Innovation Manager for > $15M NHMRC CRE, Cancer Institute NSW and philanthropy-funded Head and Neck Cancer Research at a not-for-profit comprehensive cancer center, Chris O’Brien Lifehouse Hospital (COBLH), in Sydney. She is also the operations manager for Integrated Prosthetics and Reconstruction (IPR), the first-of-its-kind cranio-maxillofacial multidisciplinary clinical service and research program in Australia engaging with a diverse range of stakeholders including clinicians, researchers, engineers, hospital executives, and commercial partners since its inception in late 2020. 

Professors Jonathan Clarke

Head & Neck Surgeon. Chris O' Brien Lifehouse

Professor Clark is the Director of Head and Neck Cancer Research at Chris O’Brien Lifehouse, the Director of Translational Research at the Royal Prince Alfred Institute of Academic Surgery, and the Inaugural Lang Walker Family Foundation Chair and Conjoint Professor in Head and Neck Cancer Reconstructive Surgery.

Professor Stefanie Feih

Professor of Mechanical Engineering, Director ofAdvanced Design and Prototyping Technologies Institute (ADaPT). Griffith University

CI Stefanie Feih is the Director of the Griffith University Advanced Design and Prototyping Technologies (ADaPT) Institute and a Professor in Mechanical Engineering at Griffith University. For more than 25 years, she has been working in both academic and industry-focused research roles on lightweight material processing and advanced design for a wide range of materials, including polymers, polymer-based composites, ceramics, and metal alloys. Most recently, her research focus has shifted to additive manufacturing opportunities for medical device technologies. Her research links structural performance to the underlying material properties and processing and manufacturing constraints and limitations.

Professors Kevin Tetsworth

Orthopaedic Surgeon - Trauma Specialty. Royal Brisbane Hospital

Kevin Tetsworth, MD, FAAOS, FRACS, FAOrthA, FIOTA
A/Prof Tetsworth is recognised internationally as an expert in deformity correction, limb lengthening, high-energy trauma, bone defects, post-traumatic limb salvage and reconstruction, osteomyelitis and fracture-related infection, minimally invasive plating of humeral shaft fractures, complex revision arthroplasty and prosthetic joint infection, as well as osseointegration for amputees. He completed his education and training in Chicago followed by 2 prestigious fellowships, one in Ilizarov surgery (Baltimore, under Prof Dror Paley) and another in osteomyelitis (Atlanta, under Prof George Cierny). Clinically active in orthopaedics for >35 years, for the past 9 years he has partnered together with Prof Munjed Al Muderis (Sydney) using osseointegration for the reconstruction of amputees. A/Prof Tetsworth’s research interests are as diverse as his clinical interests, including the biology of the Masquelet induced membrane, the nature of intra-articular fractures, the biomechanics of fracture fixation, 3D modelling and printing, tissue engineering, biomimetic scaffolds, orthopaedic infections, bone defects, osseointegration, and more. A popular invited speaker for many years, he has presented almost 1,000 formal lectures at more than 350 conferences in 32 countries on 6 continents. He has co-authored well over 250 publications, including one book and 16 book chapters, that have earned over 7,500 citations.

Dr. Nelson Alphonso

Cardiothoracic Surgeon. Queensland Paediatric and Congenital Cardiac Service, Lady Cilento Children's Hospital

Dr (PhD) Darpan Shidid

Senior Project Officer. Sydney Manufacturing Hub | The University of Sydney

Dr. Darpan Shidid is a regulatory and technical expert in the field of additive manufacturing for medical devices. Darpan is currently a Senior Project Officer at the Sydney Biomedical Accelerator and is responsible for developing operational, stakeholder engagement, and regulatory strategy for the SBA’s Biomedical Additive Manufacturing facility. Before joining SBA, Darpan served as a Senior Assessor at the Therapeutic Goods Administration. In this role, he undertook various responsibilities as a technical specialist, including the design examination of several high-risk medical devices, stakeholder engagement and education, and developing device and QMS assessment strategies for AM Personalized Devices and Therapeutic Vaping Devices. Darpan also has technical R&D experience as a research engineer for the Stryker-IMCRC project, commercializing his PhD research on automated design and additive manufacturing of personalized lattice structured implants for orthopaedic oncology. 

Dr (PhD) David Morrison

Senior Biomedical Engineer. Royal Perth Hospital | East and South Metropolitan Health Services

Dr. David Morrison is a Senior Bioengineer at the Health Technology Management Unit (HTMU) at Royal Perth Hospital.  David has experience working for a licensed (TGA, FDA, and CE-Mark) medical device manufacturer. Since joining Royal Perth Hospital in 2006, David has worked on the design and manufacturing of personalized medical devices, specializing in the provision of personalized implantable medical devices manufactured at the point of care, which operates as a state-wide service. David has been involved in two recent clinical trials evaluating new tissue-engineered methods of cranial reconstruction and has been a co-investigator on successful competitive research grants totaling more than $1.27 million. David is a co-inventor of the “Living Bone” technology, currently in human clinical trials. In addition to his role at Royal Perth Hospital, David is also a Senior Research Fellow at the WA Life Sciences Innovation Hub where he works to grow industry-university-health collaboration within the Biomedical and Health Innovation portfolio.

Mathilde Desselle

General Manager. Herston Biofabrication Institute

Mathilde Desselle is a Principal Biomedical Engineer and General Manager of the Herston Biofabrication Institute at Metro North Health, an adjunct fellow in the School of Medicine at The University of Queensland, and a PhD candidate in the Design Lab at Queensland University of Technology. 

Dr (PhD) Allison Sutherland

Deputy Director The Australian Centre for Complex Integration Surgical Solutions (ACCISS)

Dr. Allison Sutherland is an experienced clinical scientist and biomedical engineer. Having completed undergraduate studies in physical sciences and biomedicine, she went on to conduct doctoral research in vascular remodeling for cardiothoracic surgery. After completing postdoctoral fellowships in molecular oncology and heart-lung transplantation, she moved into the biopharma and biotech sector and led the pre-validation clinical programs for a world-first gene expression classifier (IVD). More recently, she has developed her own biological therapy with a focus on reconstructive and regenerative medicine, immune reprogramming, and biofabrication technology. She is currently the Deputy Director of the Australian Centre for Complex Integrated Surgical Solutions, which was transitioned into the Division of Surgery at the Princess Alexandra Hospital in 2022 for the purpose of providing preoperative surgical planning and intra-operative support by way of 3D modeling and navigation, as well as provision of patient-matched medical devices for various surgical disciplines including clinical trial investigations. 

Dr. Ashish Gupta

Orthopaedic Surgeon and Chief Executive Officer of Akunah. Akunah

Prof Ashish Gupta is an experienced orthopaedic surgeon and global leader in augmented and mixed reality for computerised nagivation in shoulder surgery. He is a subspecialist shoulder surgeon practising in Brisbane and is one of a handful of surgeons in Australia whose entire practice focuses on shoulder surgery. Prof Gupta is the founding Director of the Queensland Unit for Advanced Shoulder Research (QUASR), a dedicated biomechanical shoulder unit based at the Queensland University of Technology. He is a co-supervisor of the Brisbane Arthroplasty and Arthroscopy Fellowship which trains global orthopaedic surgeons in the subspeciality of shoulder surgery. Prof Gupta is also the founder/CEO of Akunah Medical Technologies, a medical software platform to enable personalised healthcare that aims to integrate technology with scientific, evidence-based practices to deliver equitable global healthcare.